Brand P L, Rijcken B, Schouten J P, Koëter G H, Weiss S T, Postma D S
Department of Pulmonology, University Hospital, Groningen, The Netherlands.
Am Rev Respir Dis. 1992 Aug;146(2):396-401. doi: 10.1164/ajrccm/146.2.396.
Subjects with asymptomatic airway hyperresponsiveness in epidemiologic studies may have variable airway obstruction that is not perceived as dyspnea. We tested the hypothesis that such subjects are less likely to report an increase in dyspnea during histamine-induced bronchoconstriction than symptomatic hyperresponders. A random population sample of 412 middle-aged subjects was studied. Before and after a standardized histamine challenge test, subjects recorded Borg scores for dyspnea: any increase in Borg score was considered significant. More than 80% of hyperresponsive subjects (PC10 histamine < or = 16 mg/ml) had no symptoms. The presence of prechallenge dyspnea was related to increased airways responsiveness and current smoking. An increase in Borg score was associated with younger age, more severe airway responsiveness, atopy, and female sex. The level of and increase in the Borg score were not significantly related to level and change in airway caliber (FEV1). In hyperresponsive subjects (PC10 < or = 16 mg/ml), subjects who reported dyspnea, wheeze, or asthma were more likely to show an increase in Borg score during histamine provocation than asymptomatic subjects (adjusted odds ratio 4.01, 95% confidence interval 1.01 to 16.00, p = 0.049), after adjustment for age, sex, smoking habits, FEV1, and atopy. This suggests that asymptomatic hyperresponders may have variable airway obstruction that is not recognized as breathlessness.
在流行病学研究中,患有无症状气道高反应性的受试者可能存在未被感知为呼吸困难的可变气道阻塞。我们检验了这样一个假设:与有症状的高反应者相比,这类受试者在组胺诱导的支气管收缩过程中报告呼吸困难增加的可能性较小。对412名中年受试者的随机人群样本进行了研究。在标准化组胺激发试验前后,受试者记录呼吸困难的Borg评分:Borg评分的任何增加都被视为显著。超过80%的高反应性受试者(组胺PC10≤16mg/ml)没有症状。激发前呼吸困难的存在与气道反应性增加和当前吸烟有关。Borg评分的增加与年龄较小、气道反应性更严重、特应性和女性性别有关。Borg评分的水平和增加与气道口径(FEV1)的水平和变化没有显著关系。在高反应性受试者(组胺PC10≤16mg/ml)中,报告有呼吸困难、喘息或哮喘的受试者在组胺激发过程中比无症状受试者更有可能出现Borg评分增加(调整后的优势比为4.01,95%置信区间为1.01至16.00,p = 0.049),在对年龄、性别、吸烟习惯、FEV1和特应性进行调整之后。这表明无症状高反应者可能存在未被识别为呼吸急促的可变气道阻塞。